# Losartan and HCTZ and Amlodipine vs Atenolol and Amlodipine (0954A-309)(COMPLETED)

> **NCT00140959** · PHASE4 · COMPLETED · sponsor: **Organon and Co** · enrollment: 120 (—)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** MK0954, losartan potassium/Duration of Treatment: 18 weeks
- **DRUG:** Comparator: losartan, HCTZ, amlodipine, atenolol/Duration of Treatment: 18 weeks

## Key facts

- **NCT ID:** NCT00140959
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02-01
- **Primary completion:** 2004-06-30
- **Final completion:** 2004-06-30
- **Target enrollment:** 120 (—)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00140959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00140959, "Losartan and HCTZ and Amlodipine vs Atenolol and Amlodipine (0954A-309)(COMPLETED)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00140959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*